NEW YORK (AP) — Chunky bootmaker Dr. Martens is warning of a tough year ahead. Dr. Martens shares plunged more than 30% Tuesday after the iconic British brand forecast wholesale revenue in the U.S., its largest market, would decline by double-digits compared with last year. Trading in Dr. Martens stock was temporarily halted on the London Stock Exchange early Tuesday as it sank to a record-low 0.64 pounds, according to FactSet. That could translate into a sizeable hit to profits, with the company pointing to a base projected impact of 20 million pounds ($24.9 million) on pretax earnings year-over-year. In-season orders from wholesale customers could help ease U.S. revenue expectations, the company noted, but those are difficult to predict. |
Blinken, in Shanghai, begins expected contentious talks with Chinese officialsDefending champion Golden Knights beat Stars 3TikTok bows to European pressure and halts reward feature on new app in France and SpainUS growth likely slowed last quarter but still pointed to a solid economyIndustrial robot makers gear up for global expansionWorld Central Kitchen workers killed by Israeli strikes in Gaza will be honored at memorialMaple Leafs forward William Nylander sits out 3rd straight game to open the playoffsShohei Ohtani's hardHow do private enterprises tackle challenges with innovation?World Central Kitchen workers killed by Israeli strikes in Gaza will be honored at memorial